Algeria - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
In 2017, the country was number 191 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 44 Cases. India lead the ranking with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2017 | 44.00 |
| 2016 | 31.00 |
| 2015 | 63.00 |
| 2014 | 65.00 |
| 2013 |
Download all data from 2005 to 2017
How does Algeria rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 181 |
#181
Yemen
|
51 | 2019 | +2.0 % | -0.8 % | View data | |
| 191 |
#191
Algeria
|
44 | 2017 | +41.9 % | NA | View data | |
| 194 |
#194
Equatorial Guinea
|
38 | 2019 | +40.7 % | +40.3 % | View data | |